Monod Bio Announces Publication in Nature Highlighting De Novo Protein Technology Platform for the Creation of Novel Luciferases
Retrieved on:
Wednesday, February 22, 2023
Biotechnology, Technology, Health, Pharmaceutical, Other Science, Research, Infectious Diseases, Software, Genetics, Science, Clinical Trials, Monod, Protein, Paper, University, De novo protein structure prediction, De novo, University of Washington Department of Bioengineering, Algorithm, Howard Hughes Medical Institute, UW, Enzyme, University of Washington School of Medicine, Bio, Machine learning, Luciferin, Biochemistry, IPD, Luciferase, Rare-earth element, Fine chemical, Medicine, Nature
As reported in the journal Nature, a team based at the Institute for Protein Design (IPD) at UW Medicine devised machine-learning algorithms that can create light-emitting enzymes called luciferases.
Key Points:
- As reported in the journal Nature, a team based at the Institute for Protein Design (IPD) at UW Medicine devised machine-learning algorithms that can create light-emitting enzymes called luciferases.
- Combining these biosensors with the de novo luciferases will create new commercial opportunities for Monod Bio.
- “LuxSit and its underlying de novo protein design technology are fundamental to what we are developing at Monod Bio.
- “We continue using LuxSit, machine learning, and de novo protein design to advance our unique biosensor pipeline aimed to improve human health.